Ovid Therapeutics's total assets for Q1 2025 were $81.65M, a decrease of -11.41% from the previous quarter. OVID total liabilities were $22.38M for the fiscal quarter, a -6.53% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.